Yokom, D.W. et al. 2018. Prognostic and predictive clinical factors in patients with metastatic castration-resistant prostate cancer treated with cabazitaxel. Canadian Urological Association Journal. 12, 8 (Mar. 2018). DOI:https://doi.org/10.5489/cuaj.5108.